Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study

Okello E. et al, (2021), The Lancet Global Health, 9, e1423 - e1430

Critical needs in advancing Shigella vaccines for global health

MacLennan CA. et al, (2021), The Journal of Infectious Diseases

Paths and timings of the peopling of Polynesia inferred from genomic networks.

Ioannidis AG. et al, (2021), Nature, 597, 522 - 526

Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination

Johnson M. et al, (2021), Frontiers in Tropical Diseases, 2

Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.

Figueroa JP. et al, (2021), PLoS medicine, 18

Individual-level variations in malaria susceptibility and acquisition of clinical protection

Valletta JJ. et al, (2021), Wellcome Open Research, 6, 22 - 22

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).

Flaxman A. et al, (2021), Lancet, 398, 981 - 990

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques.

Bewley KR. et al, (2021), Science advances, 7

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles

Gimenez AM. et al, (2021), SCIENTIFIC REPORTS, 11

Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals

Machipisa T. et al, (2021), JAMA Cardiology, 6, 1000 - 1000

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.

McAuliffe J. et al, (2021), J Immunother Cancer, 9

Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.

Youngs J. et al, (2021), PLoS Pathog, 17

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus.

Lin G-L. et al, (2021), Nature communications, 12

A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data.

Phillips MT. et al, (2021), Statistics in medicine

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

Skelly DT. et al, (2021), Nature communications, 12

Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infection.

Moysi E. et al, (2021), European journal of immunology

Maintaining laboratory quality assurance and safety in a pandemic: Experiences from the KEMRI-Wellcome Trust Research Programme laboratory’s COVID-19 response

Gumba H. et al, (2021), Wellcome Open Research, 6, 205 - 205

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial.

Qadri F. et al, (2021), Lancet (London, England)

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

Liu X. et al, (2021), Lancet

Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)

Butler C. et al, (2021), Vaccines, 9, 851 - 851

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?